Contraception
Volume 76, Issue 2 , Pages 132-138 , August 2007

Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents

  • Young A Han

      Affiliations

    • Postdoctoral associate. Tel.: +1 212 746 3410; fax: +1 212 746 4964.
    • ,
  • Mukul Singh
    • ,
  • Brij B. Saxena

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 212 746 3067; fax: +1 212 746 4964.

Received 27 December 2006 ,Revised 19 March 2007 ,Accepted 14 April 2007.

References 

  1. Mulders TMT, Dienben TOM, Coelingh B, Herjan JT. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod. 2002;17:2594–2599
  2. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet. 2003;361:1159–1167
  3. Moreno V, Bosch FX, Munoz N, et al. Long-term use of oral contraceptives and a high number of children increase the risk of cervical cancer in women with HPV infection. Lancet. 2002;359:1085–1092
  4. Steiner MJ, Cates W. Condoms and urinary tract infections: is nonoxynol 9 the problem or the solution?. Epidemiology. 1997;8:612–614
  5. Renner R. European bans on surfactant trigger transatlantic debate. Environ Sci Technol. 1997;31:A316–A320
  6. Saxena BB, Singh M, Gospin RM, Chu CC, Ledger WJ. Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system. Contraception. 2004;70:213–219
  7. World Health Organization . Sperm–cervical mucus interaction. In: WHO laboratory manual for the examination of human semen and sperm–cervical mucus interaction. 4th ed.. New York: Cambridge University Press; 1999;p. 51–59
  8. Welcher F. Phenanthriline. In:  Fuman NH editors. Standard methods of chemical analysis. 6th ed.. Princeton, NJ: Van Nostrand Company; 1962;p. 910–911
  9. Roe JH. l-Ascorbic acid. In:  Seligson D editors. Standard methods of clinical chemistry. New York: Academia Press; 1961;p. 33–35
  10. Apraxia. In: The Merck Index: an encyclopedia of chemicals, drugs and biologicals. Whitehouse Station, NJ: Merck; 1996. pp. 699, 1037.
  11. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med. 1990;322:941–949
  12. Hong CY, Lee MF, Lai LF, et al. Effect of lipid peroxidation on beating frequency of human sperm tail. Andrologia. 1994;26:61–65
  13. Aiken RJ, Harris D, Buckingham D. Relationship between iron catalyzed lipid peroxidation potential and human sperm function. J Reprod Fertil. 1993;98:257–265
  14. Calamera JC, Giovenco P, Quiros MC, et al. Effect of lipid peroxidation upon human spermatic adenosinetriphosphate (ATP). Relationship with motility, velocity and linearity of the spermatozoa. Andrologia. 1989;21:48–54
  15. Jones R, Mann T. Lipid peroxidation in spermatozoa. Proc R Soc Lond B Biol Sci. 1973;184:103–107
  16. Jones R, Mann T. Lipid peroxides in spermatozoa formation, role of plasmologen and physiological significance. Proc R Soc Lond B Biol Sci. 1976;193:317–333
  17. Jones R, Mann T. Damage to ram spermatozoa formation, role of plasmologen and physiological significance. J Reprod Fertil. 1977;50:261–268
  18. Jones R, Mann T, Sherins RJ. Adverse effects of peroxidized lipids on human spermatozoa. Proc R Soc Lond B Biol Sci. 1978;201:413–417
  19. Roy S, Mishell D. Status of research and development of vaginal contraceptive rings as fertility control method in the female. Res Front Fertil Regul. 1983;2:1–10
  20. Nguyen NY, Chrambach A. Stabilization of pH gradients formed by ampholine. Anal Biochem. 1977;82(Pt 1):226–235
  21. FDA . Proposed affirmation of GRAS status for gum Arabic. Fed Regist. 1974;39:34203–34208
  22. Calnan JS, Pflug JJ, Chhabra AS, Raghupati N. Clinical and experimental studies of polyhydroxyethylmethacrylate gel (“hydron”) for reconstructive surgery. Br J Plast Surg. 1971;24:113–124
  23. Jason SB, Catherine AM, Molly SS, Miles J, Rajiv M. Long-term in vivo biomechanical properties and biocompatibility of poly(2-hydroxyethylmethacrylate-co-methyl methacrylate) nerve conduits. Biomaterials. 2005;26:1741–1749
  24. Hashimoto F, Kashiwada Y, Cosentino LM, Chen CH, Garrett PE, Lee KH. Anti-AIDS agents—XXVII. Synthesis and anti-HIV activity of butulinic acid and dihydrobetulinic acid derivatives. Bioorg Med Chem. 1997;5:2133–2143
  25. Ito J, Chang FR, Wang HK, et al. Anti-AIDS agents: 48. Activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis. J Nat Prod. 2001;64:1278–1281

☆ Funding for this research was provided by MollyLou Foundation and Institutional funds.

PII: S0010-7824(07)00174-6

doi: 10.1016/j.contraception.2007.04.006

Contraception
Volume 76, Issue 2 , Pages 132-138 , August 2007

Article Tools

* Image Usage & Resolution